TSRO Market Cap History
Below is a table of the TSRO market cap history going back to 6/28/2012:

Date TSRO Market Cap
6/28/2012365.12M
7/27/2012368.30M
10/25/2012412.58M
2/1/2013497.41M
4/25/2013794.93M
7/25/20131.18B
11/7/20131.10B
3/11/20141.09B
4/30/2014898.45M
7/21/2014994.79M
10/30/20141.03B
2/19/20151.49B
4/24/20152.56B
7/30/20152.30B
10/26/20151.82B
2/24/20161.53B
5/2/20161.92B
8/2/20164.91B
10/31/20166.24B
2/24/201710.02B
5/3/20177.58B
8/3/20176.75B
11/3/20176.03B
2/22/20183.32B
4/30/20182.79B
7/30/20181.89B
10/29/20181.70B

Also see: TSRO Shares Outstanding History
and TSRO YTD Return
TSRO Historical Market Cap:
+27.43% CAGR
TSRO Historical Market Cap: +27.43% CAGR

Mouse over chart for data details
6/28/2012 ...10/29/2018
TESARO is a biopharmaceutical company focused on providing therapies to people facing cancer. Co.'s primary focus is to develop treatments for tumors using various approaches, including small molecules and immuno-oncology antibodies, as monotherapies or in combinations. Co.'s products are: ZEJULA® (niraparib), which is for the maintenance treatment of women with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer; and VARUBI® (rolapitant), a neurokinin, receptor antagonist for the prevention of chemotherapy induced nausea and vomiting. Co. is evaluating its immuno-oncology anti-tumor agents in combination studies with niraparib and other anti-tumor agents. We show 27 historical shares outstanding datapoints in our TSRO shares outstanding history coverage, used to compute TSRO market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing TSRO market cap history over the course of time is important for investors interested in comparing TSRO's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of TSRO versus a peer is one thing; comparing TSRO market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like TSRO can fluctuate over the course of history. With this page we aim to empower investors researching TSRO by allowing them to research the TSRO market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for TSRO:
TSRO SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Tesaro (TSRO) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

TTNP Market Cap History
TTOO Market Cap History
TTPH Market Cap History
TVTY Market Cap History
TXMD Market Cap History
TYME Market Cap History
UHS Market Cap History
USPH Market Cap History
UTHR Market Cap History
UTMD Market Cap History
More Healthcare companies »

 

TSRO Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.